appointments

News

AbbVie's new chief scientific officer Roopal Thakkar (l), who is replacing Thomas Hudson (r)

AbbVie lines up Thakkar to replace outgoing CSO Hudson

There is change at the top of AbbVie’s R&D organisation, as chief scientific officer Thomas Hudson announces his retirement after four years in the role.

News

Mikael Dolsten exits Pfizer, putting R&D leadership in flux

Pfizer’s chief scientific officer and president of R&D, Mikael Dolsten, has said he will step down from the role in the coming months, kicking off the search for a successor.

Digital

Changing Faces: Digital and supplier hires from April 2024

Finally, we wrap up the belated April hires round-ups with our “pharma supplier” round-up inclusive of tech vendors, CROs, CDMOs, and others adjacent to the space.

Sales & Marketing

Changing Faces: Agency, consultancy, and investor hires from...

With apologies for the lateness, we didn’t want to miss the opportunity to acknowledge the many moves in the pharma agency space in April.

R&D

Changing Faces: Pharma and biotech hires from April 2024

Coming to you well over a month late, we still want to acknowledge the many comings and goings we saw in the biotech industry in April.

News

Ex-Jazz, Sunesis exec Swisher takes over at NodThera

Anglo-US biotech NodThera has named former Jazz Pharma executive Dan Swisher as its new chief executive, replacing Alan Watt, who will take on the dual roles of president

AbbVie lines up Thakkar to replace outgoing CSO Hudson

Mikael Dolsten exits Pfizer, putting R&D leadership in flux

Changing Faces: Digital and supplier hires from April 2024

Changing Faces: Agency, consultancy, and investor hires from...

Changing Faces: Pharma and biotech hires from April 2024

Ex-Jazz, Sunesis exec Swisher takes over at NodThera

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

appointments

Editor's Picks